Ultra-structural cell distribution of the melanoma marker iodobenzamide: Improved potentially of SIMS imaging in life sciences

BioMedical Engineering Online

Volumn 3, Issue , 2004, Pages

  Guerquin Kern, Jean Luc ^a   Hillion, François ^b   Madelmont, Jean Claude ^a   Labarre, Pierre ^a   Papon, Janine ^a   Croisy, Alain ^a  

^a INSERM   (France)

^b CAMECA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARBON; CELL PROTEIN; CYANIDE; DIAGNOSTIC AGENT; IODINE; ION; MELANIN; MEMBRANE RECEPTOR; N 2 DIETHYLAMINOETHYL 4 IODOBENZAMIDE; NITROGEN; NUCLEIC ACID; PHOSPHORUS; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; N-(2-(DIETHYLAMINO)ETHYL)-4-IODOBENZAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOMEDICINE; BIOSYNTHESIS; CANCER CELL; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER THERAPY; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG DISTRIBUTION; DRUG SPECIFICITY; HISTOPATHOLOGY; IMAGING SYSTEM; INOCULATION; INTERNALIZATION; LUNG PARENCHYMA; LUNG TUMOR; MASS SPECTROMETRY; MEDICAL INSTRUMENTATION; MELANOMA; MELANOMA B16; MELANOSOME; METASTASIS; MICROSCOPY; MOUSE; MOUSE STRAIN; NONHUMAN; SCINTIGRAPHY; TISSUE SECTION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL COMPARTMENTALIZATION; CHEMISTRY; EXPERIMENTAL MELANOMA; PROCEDURES; SECONDARY; SECONDARY ION MASS SPECTROMETRY; ULTRASTRUCTURE;

ANIMALS; BENZAMIDES; CELL COMPARTMENTATION; LUNG NEOPLASMS; MELANINS; MELANOMA, EXPERIMENTAL; MELANOSOMES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; SPECTROMETRY, MASS, SECONDARY ION;

EID: 3042601124     PISSN: 1475925X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-925X-3-10     Document Type: Article

References (19)

1. Castaing R, Slodzian G: Microanalyse par émission ionique secondaire. J Microsc 1962, 1:395-410.
2. Galle P: Sur une nouvelle méthode d'analyse cellulaire utilisant le phénomène d'émission ionique secondaire. Ann Phys Biol Med 1970, 42:83-94.
3. Morrison GH, Gay I, Chandra S: Ion microscopy in biology. Scanning Microsc Suppl 1994, 8:359-70.
4. Pacholski ML, Winograd N: Imaging with mass spectrometry. Chem Rev 1999, 99:2977-3005.
5. Todd PJ, Schaaff TG, Chaurand P, Caprioli RM: Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization. J Mass Spectrom 2001, 36:355-69.
6. Slodzian G, Daigne B, Girard F, Boust F, Hillion F: Scanning secondary ion analytical microscopy with parallel detection. Biol Cell 1992, 74:43-50.
7. Hillion F, Daigne B, Girard F, Slodzian G, Schuhmacher M: A new high performance SIMS instrument: The Cameca "Nanosims 50". Secondary Ion Mass Spectrometry SIMS IX 1993:254-257.
8. Weinstock MA: Epidemiology of melanoma. Cancer Treat Res 1993, 65:29-56.
9. Garbe C, Blum A: Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001, 14:280-90.
10. Prichard RS, Hill AD, Skehan SJ, O'Higgins NJ: Positron emission tomography for staging and management of malignant melanoma. Br J Surg 2002, 89:389-96.
11. Michelot JM, Moreau MF, Labarre PG, Madelmont JC, Veyre AJ, Papon JM, Parry DF, Bonafous JF, Boire JY, Desplanches GG: Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med 1991, 32:1573-80.
12. John CS, Saga T, Kinuya S, Le N, Jeong JM, Paik CH, Reba RC, Varma VM, McAfee JG: An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma. Nucl Med Biol 1993, 20:75-9.
13. Labarre P, Papon J, Moreau MF, Moins N, Veyre A, Madelmont JC: Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting. Eur J Nucl Med 1999, 26:494-8.
14. Moins N, Papon J, Seguin H, Gardette D, Moreau MF, Labarre P, Bayle M, Michelot J, Gramain JC, Madelmont JC, Veyre A: Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents. Nucl Med Biol 2001, 28:799-808.
15. Labarre P, Papon J, Moreau MF, Moins N, Bayle M, Veyre A, Madelmont JC: Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent. Melanoma Res 2002, 12:115-21.
16. Moins N, D'Incan M, Bonafous J, Bacin F, Labarre P, Moreau MF, Mestas D, Noirault E, Chossat F, Berthommier E, Papon J, Bayle M, Souteyrand P, Madelmont JC, Veyre A: 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur J Nucl Med Mol Imaging 2002, 29:1478-84.
17. Chehade F, De Labriolle-Vaylet C, Michelot J, Moins N, Moreau MF, Hindie E, Papon J, Escaig F, Galle P, Veyre A: Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy. Cell Mol Biol (Noisy-le-grand) 2001, 47:529-34.
18. John CS, Bowen WD, Saga T, Kinuya S, Vilner BJ, Baumgold J, Paik CH, Reba RC, Neumann RD, Varma VM: A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl) 4-iodobenzamide. J Nucl Med 1993, 34:2169-75.
19. Caveliers V, Everaert H, Lahoutte T, Dierickx LO, John CS, Bossuyt A: Labelled sigma receptor ligands: can their role in neurology and oncology be extended? Eur J Nucl Med 2001, 28:133-5.